The use of ustekinumab in a patient with severe psoriasis and positive HBV serology
Author:
Affiliation:
1. Complexo Hospitalar Santa Casa de Misericórdia de Porto Alegre, Brazil
Publisher
FapUNIFESP (SciELO)
Subject
Dermatology
Link
http://www.scielo.br/pdf/abd/v89n4/0365-0596-abd-89-04-0652.pdf
Reference8 articles.
1. Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: a review and recommendations for management;Abramson A;J Am Acad Dermatol,2012
2. Psoriasis;Arruda LHF;An bras Dermatol,,2001
3. Ustekinumab: differential use in psoriasis;Uhlenhake EE;Clin Cosmet Investig Dermatol,2011
4. Safety of anti-tumour necrosis factor-a agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the literature;Fotiadou C;J Eur Acad Dermatol Venereol,2011
5. Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in an HBsAg negative anti-HBs positive patient;Koskinas J;Br J Dermatol,2013
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors;Rheumatology;2024-08-17
2. Hepatitis B Virus Reactivation and Mycobacterial Infections Associated With Ustekinumab: A Retrospective Study of an International Pharmacovigilance Database;Frontiers in Pharmacology;2022-07-04
3. Expression of genes related to inflammation – IL-6, IL-8, and IFN-γ in monitoring ustekinumab therapy: preliminary results;Advances in Dermatology and Allergology;2022
4. Safety of therapies using ustekinumab in patients with psoriasis who have had hepatitis B virus infection;Dermatologic Therapy;2021-12-28
5. Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics;World Journal of Gastroenterology;2021-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3